{"DataElement":{"publicId":"2793530","version":"1","preferredName":"Treatment Regimen Pharmacologic Substance Type","preferredDefinition":"Text term to represent the pharmaceutical classification of a disease treatment regimen. [Manually-curated]","longName":"TX_REG_PHARM_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2793525","version":"1","preferredName":"Treatment Regimen Pharmacologic Substance Description","preferredDefinition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment._An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._A written or verbal account, representation, statement, or explanation of something.","longName":"TX_REG_PHARM_DESC","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2224094","version":"1","preferredName":"Treatment_Regimen","preferredDefinition":"Treatment schedule for the pre-clinical trial / therapeutic experiment describing the dosages of the drug and the times of the treatment.","longName":"C15697","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment Regimen","conceptCode":"C15697","definition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F1FF3-7030-5656-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2793523","version":"1","preferredName":"Pharmacologic Substance Description","preferredDefinition":"A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.:Description; a statement that represents something in words.","longName":"C1909:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58CDD503-DE3B-69E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"ONEDATA","dateModified":"2008-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58CDD503-DE4C-69E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2793527","version":"1","preferredName":"Treatment Regimen Pharmacologic Substance Type","preferredDefinition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment._An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._Type; a subdivision of a particular kind of thing.","longName":"TX_REG_PHARM_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Targeted Molecular Therapy","valueDescription":"Targeted Molecular Therapy","ValueMeaning":{"publicId":"2793528","version":"1","preferredName":"Targeted Molecular Therapy","longName":"2793528","preferredDefinition":"Cancer therapies designed to act upon specific molecules in metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Targeted Molecular Therapy","conceptCode":"C76243","definition":"Cancer therapies designed to act upon specific molecules in metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58CF3726-EEC8-0691-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58CF3726-EEE1-0691-E044-0003BA3F9857","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"REEVESD","dateModified":"2008-10-09","deletedIndicator":"No"},{"value":"Hormone therapy","valueDescription":"Hormone Therapy","ValueMeaning":{"publicId":"2580225","version":"1","preferredName":"Hormone Therapy","longName":"2580225","preferredDefinition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-066E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-12","modifiedBy":"ONEDATA","dateModified":"2006-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58CF3726-EEF6-0691-E044-0003BA3F9857","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"REEVESD","dateModified":"2008-10-09","deletedIndicator":"No"},{"value":"Immunotherapy","valueDescription":"Immunotherapy","ValueMeaning":{"publicId":"2570354","version":"1","preferredName":"Immunotherapy","longName":"2570354","preferredDefinition":"(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DFDF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58CF3726-EF02-0691-E044-0003BA3F9857","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"REEVESD","dateModified":"2008-10-09","deletedIndicator":"No"},{"value":"Chemotherapy","valueDescription":"Chemotherapy","ValueMeaning":{"publicId":"2570169","version":"1","preferredName":"Chemotherapy","longName":"2570169","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF26-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2022-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58CF3726-EF0E-0691-E044-0003BA3F9857","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"REEVESD","dateModified":"2008-10-09","deletedIndicator":"No"},{"value":"Other, specify in notes","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B865309-6E47-E649-E040-BB89AD436FB4","beginDate":"2010-07-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-16","modifiedBy":"ONEDATA","dateModified":"2010-07-16","deletedIndicator":"No"},{"value":"Vaccine","valueDescription":"Vaccine","ValueMeaning":{"publicId":"2958076","version":"1","preferredName":"Vaccine","longName":"2958076","preferredDefinition":"Suspensions of killed or attentuated microorganisms (bacteria, viruses, or rickettsiae), or of antigenic proteins derived from them, administered for the prevention, amelioration, or treatment of infectious diseases or cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaccine","conceptCode":"C923","definition":"Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"779FFFA3-EFE3-61A0-E040-BB89AD433786","latestVersionIndicator":"Yes","beginDate":"2009-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-11-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B31E93B2-E6A9-4D57-E040-BB89AD4357E6","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","deletedIndicator":"No"},{"value":"Ancillary","valueDescription":"Secondary Pharmacologic Substance","ValueMeaning":{"publicId":"3320097","version":"1","preferredName":"Secondary Pharmacologic Substance","longName":"3320097","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.: A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31E93B2-E6B7-4D57-E040-BB89AD4357E6","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B31E93B2-E6D0-4D57-E040-BB89AD4357E6","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DC9D1490-8E05-5488-E040-BB89AD434251","beginDate":"2013-05-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-13","modifiedBy":"ONEDATA","dateModified":"2013-05-13","deletedIndicator":"No"},{"value":"Chemotherapy/Hormone Therapy","valueDescription":"Chemotherapy Endocrine Therapy","ValueMeaning":{"publicId":"4722992","version":"1","preferredName":"Chemotherapy Endocrine Therapy","longName":"4722992","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.: Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FC23548-92F0-2F46-E050-BB89AD4307CE","latestVersionIndicator":"Yes","beginDate":"2015-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FC23548-9309-2F46-E050-BB89AD4307CE","beginDate":"2015-02-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-02-23","modifiedBy":"ONEDATA","dateModified":"2015-02-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2793526","version":"1","preferredName":"Treatment Regimen Pharmacologic Substance Type","preferredDefinition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.:A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.:Type; a subdivision of a particular kind of thing.","longName":"C15697:C1909:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Treatment Regimen","conceptCode":"C15697","definition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58CF3726-EEA1-0691-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"ONEDATA","dateModified":"2008-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58CF3726-EEB2-0691-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"COOPERM","dateModified":"2015-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"},{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787504","version":"1","longName":"GBM","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787510","version":"1","longName":"LGG","context":"NCIP"},{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"}]},{"publicId":"5655939","version":"1","longName":"BLGSP (Burkitt Lymphoma Genome Sequencing Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000268","version":"1","longName":"Initial Treatment and Followup Form","context":"OCG"}]}],"AlternateNames":[{"name":"Therapy Type","type":"TCGA_Name","context":"NCIP"},{"name":"therapy_type","type":"TCGA_XML_Name","context":"NCIP"},{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Pharmaceutical type","type":"Preferred Question Text","description":"Pharmaceutical type","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"58CF45BE-E567-0A9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-10-09","modifiedBy":"TSESU","dateModified":"2018-07-10","changeDescription":"Reviewed and approved for release by TCGA team on 1/8/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}